Health TrialsbyHealthPanel

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer

A Phase 1/2, Open-Label, First-in-Human Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumour Activity of ODM-216 in Participants With Advanced Solid Tumours

Participants needed: 195
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Orion Corporation, Orion PharmaUpdated: Sep 24, 2026Locations: 7
Eligibility criteria

Understand the trial procedures and agree to participate by giving written, sign... [+3]

Received prior chemotherapy, targeted therapy, or treatment with an investigatio... [+3]

Read more
Status: Recruiting

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Multi-site, open-label, first-in-human study with 2 parts (dose escalation and dose expansion) in subjects with selected advanced solid tumours

Participants needed: 315
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Orion Corporation, Orion PharmaUpdated: May 8, 2026Locations: 20
Eligibility criteria

Male or female subjects ≥18 years old [+18]

Other malignancy active within the previous 2 years except for basal cell or squ... [+21]

Read more
Status: Recruiting

A 2-part Phase 1/2 Open-label Trial on ODM-212

An open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)

Participants needed: 229
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Orion Corporation, Orion PharmaUpdated: May 4, 2026Locations: 2
Eligibility criteria

Male or female participants ≥18 years old. [+14]

Other malignancy active within the previous 2 years except for basal cell or squ... [+14]

Read more